TENS and Heat for Reducing Back Pain in Humans

November 13, 2018 updated by: Future Sciene Technology

The Effect of 4 Hours of Tens and Heat on Pain and Range of Motion in the Lower Back and the Duration of Pain Relief After Tens and Heat Are Removed

Lower back pain is one of the most common and most expensive impairments costing time and expense in the work force today. With the effects on cognitive skills and addictive side effects of opioids and other prescription pain killers, there has been increasing interest in alternative medical treatments to relieve pain. Two of these that are commonly used are heat and transcutaneous electrical nerve stimulation (TENS). In the present investigation, there are two objectives 1) to determine if Tens needs to be continuous or can be intermittent and still achieve pain relief and 2) To see how long pain relief lasts after 4 hours of application of tens, heat or both. There will be seventy-five subjects with chronic back pain divided into 6 groups randomly; 15 subjects per group. The intervention will be either TENS alone, Heat alone or Tens plus heat or a control group.

Study Overview

Detailed Description

There will be seventy-five subjects with chronic back pain divided into 6 groups randomly; 15 subjects per group. They are between the ages of 24 and 60 years old. They will not be taking pain medications for at least 48 hours prior to the study. The groups were as follows;

  1. Control
  2. heat only
  3. Tens only
  4. Tens and heat
  5. Tens for the last 15 minutes each hour plus heat
  6. Tens for the last 15 minutes each hour Tens is at threshold intensity (12 ma) at a frequency of 20 Hz either ramped continuously or for the last 15 minutes of each hour. The stimulation is 3 seconds increase to threshold, 3 seconds hold and 3 seconds ramped down followed by a 9 second rest period. Pain is assessed by an analog visual pain scale and an algometer placing pressure on the back to assess the pressure that causes pain, a measure of inflammation. In addition, the Oswestry lower back pain index and Roland Morris questionnaire are used. Range of motion in the trunk where first pain is felt is also measured.

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nevada
      • Henderson, Nevada, United States, 89113
        • Recruiting
        • Future Sciecne Technology
        • Contact:
          • jerrold petrofsky, ph d

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 56 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. pain for at least 3 months in the lower back
  2. age range 24-60

Exclusion Criteria:

  1. Those with back pain caused by fractures or spinal damage
  2. those who had undergone low back surgery within the last year
  3. those with diagnosed diabetes
  4. no use of opiod pain meds for at least 10 days

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: control
sham heat and sham TENS
expended heat wrap
tens applied but unit not turned on
Experimental: heat only
heat applied to the back for 4 hours with sham TENS
tens applied but unit not turned on
low level continuous heat wrap
Experimental: Tens only
Tens applied for 4 hours with sham heat
expended heat wrap
electrical stimulation
Experimental: Heat and Tens continuous
Heat and Tens applied together for 4 hours
low level continuous heat wrap
electrical stimulation
Experimental: Tens 15
Tens applied only 15 minutes each hour for 4 hours, sham heat
expended heat wrap
electrical stimulation
Experimental: Heat and Tens 15
Heat applied for 4 hours with tens only applied the last 15 minutes of each hour
low level continuous heat wrap
electrical stimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
range of motion of the hip for flexion, extension,left and right rotation,left and right bending
Time Frame: Baseline (beginning of study before intervention)
range of motion in 6 degrees of freedom in the lower back
Baseline (beginning of study before intervention)
subjective pain by marking on scale
Time Frame: Baseline (beginning of study before intervention)
analog visual pain scale on separate piece of paper 10cm in length- subject marks pain level with 10 the worst
Baseline (beginning of study before intervention)
pressure on back that causes pain
Time Frame: Baseline (beginning of study before intervention)
pressure applied to lower back until pain is felt to assess inflammation
Baseline (beginning of study before intervention)
range of motion of the hip for flexion, extension,left and right rotation,left and right bending
Time Frame: 4 hours after study start- at end of intervention
range of motion in 6 degrees of freedom in the lower back
4 hours after study start- at end of intervention
subjective pain by marking on scale
Time Frame: 4 hours after study start- at end of intervention
analog visual pain scale on separate piece of paper 10cm in length- subject marks pain level with 10 the worst
4 hours after study start- at end of intervention
pressure on back that causes pain
Time Frame: 4 hours after study start- at end of intervention
pressure applied to lower back until pain is felt to assess inflammation
4 hours after study start- at end of intervention
range of motion of the hip for flexion, extension,left and right rotation,left and right bending
Time Frame: 10 hours after study start( 6 hours after the modality ends)
range of motion in 6 degrees of freedom in the lower back
10 hours after study start( 6 hours after the modality ends)
subjective pain by marking on scale
Time Frame: 10 hours after study start( 6 hours after the modality ends)
analog visual pain scale on separate piece of paper 10cm in length- subject marks pain level with 10 the worst
10 hours after study start( 6 hours after the modality ends)
pressure on back that causes pain
Time Frame: 10 hours after study start( 6 hours after the modality ends)
pressure applied to lower back until pain is felt to assess inflammation
10 hours after study start( 6 hours after the modality ends)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mike Laymon, PT, DSC, Future Science Technology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2018

Primary Completion (Anticipated)

December 31, 2018

Study Completion (Anticipated)

December 31, 2018

Study Registration Dates

First Submitted

November 8, 2018

First Submitted That Met QC Criteria

November 13, 2018

First Posted (Actual)

November 14, 2018

Study Record Updates

Last Update Posted (Actual)

November 14, 2018

Last Update Submitted That Met QC Criteria

November 13, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • jand m18

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on sham heat

Subscribe